ACET
Price
$0.76
Change
-$0.02 (-2.56%)
Updated
Jul 25 closing price
Capitalization
64.16M
11 days until earnings call
NWPHF
Price
$9.36
Change
-$2.64 (-22.00%)
Updated
Sep 9 closing price
Capitalization
177.35M
Interact to see
Advertisement

ACET vs NWPHF

Header iconACET vs NWPHF Comparison
Open Charts ACET vs NWPHFBanner chart's image
Adicet Bio
Price$0.76
Change-$0.02 (-2.56%)
Volume$123.2K
Capitalization64.16M
Newron Pharmaceuticals SPA
Price$9.36
Change-$2.64 (-22.00%)
Volume$500
Capitalization177.35M
ACET vs NWPHF Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. NWPHF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and NWPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ACET: $0.77 vs. NWPHF: $9.36)
Brand notoriety: ACET and NWPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 30% vs. NWPHF: 100%
Market capitalization -- ACET: $64.16M vs. NWPHF: $177.35M
ACET [@Biotechnology] is valued at $64.16M. NWPHF’s [@Biotechnology] market capitalization is $177.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileNWPHF’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • NWPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, ACET is a better buy in the long-term than NWPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish.

  • ACET’s TA Score: 5 bullish, 5 bearish.

Price Growth

ACET (@Biotechnology) experienced а +1.58% price change this week, while NWPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NWPHF($177M) has a higher market cap than ACET($64.2M). NWPHF YTD gains are higher at: 0.000 vs. ACET (-19.802).
ACETNWPHFACET / NWPHF
Capitalization64.2M177M36%
EBITDA-110.82MN/A-
Gain YTD-19.8020.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash150MN/A-
Total Debt16.2MN/A-
FUNDAMENTALS RATINGS
ACET vs NWPHF: Fundamental Ratings
ACET
NWPHF
OUTLOOK RATING
1..100
1842
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
10010
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5076
P/E GROWTH RATING
1..100
19100
SEASONALITY SCORE
1..100
n/a42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (30) in the Medical Distributors industry is somewhat better than the same rating for NWPHF (65) in the null industry. This means that ACET’s stock grew somewhat faster than NWPHF’s over the last 12 months.

NWPHF's Profit vs Risk Rating (10) in the null industry is significantly better than the same rating for ACET (100) in the Medical Distributors industry. This means that NWPHF’s stock grew significantly faster than ACET’s over the last 12 months.

ACET's SMR Rating (97) in the Medical Distributors industry is in the same range as NWPHF (100) in the null industry. This means that ACET’s stock grew similarly to NWPHF’s over the last 12 months.

ACET's Price Growth Rating (50) in the Medical Distributors industry is in the same range as NWPHF (76) in the null industry. This means that ACET’s stock grew similarly to NWPHF’s over the last 12 months.

ACET's P/E Growth Rating (19) in the Medical Distributors industry is significantly better than the same rating for NWPHF (100) in the null industry. This means that ACET’s stock grew significantly faster than NWPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETNWPHF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
10%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EVSAX25.10N/A
N/A
Allspring Disciplined US Core A
TGDIX16.83N/A
N/A
TCW Relative Value Large Cap I
VZICX31.56N/A
N/A
Vanguard International Core Stock Adm
FWOCX17.13N/A
N/A
Fidelity Advisor Women's Leadership C
SUGAX9.74N/A
N/A
Victory Pioneer Global Growth A

NWPHF and

Correlation & Price change

A.I.dvisor tells us that NWPHF and MMIRF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWPHF and MMIRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWPHF
1D Price
Change %
NWPHF100%
N/A
MMIRF - NWPHF
30%
Poorly correlated
N/A
ACET - NWPHF
27%
Poorly correlated
-0.54%
NTRB - NWPHF
19%
Poorly correlated
-3.18%
NURPF - NWPHF
7%
Poorly correlated
N/A
PRVCF - NWPHF
4%
Poorly correlated
N/A
More